Takip et
Benjamin Meyer
Benjamin Meyer
Group leader, University of Geneva
unige.ch üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study
S Stringhini, A Wisniak, G Piumatti, AS Azman, SA Lauer, H Baysson, ...
The Lancet 396 (10247), 313-319, 2020
12272020
Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study
CBEM Reusken, BL Haagmans, MA Müller, C Gutierrez, GJ Godeke, ...
The Lancet infectious diseases 13 (10), 859-866, 2013
9412013
Serological assays for emerging coronaviruses: challenges and pitfalls
B Meyer, C Drosten, MA Müller
Virus research 194, 175-183, 2014
5142014
Human betacoronavirus 2c EMC/2012–related viruses in bats, Ghana and Europe
A Annan, HJ Baldwin, VM Corman, SM Klose, M Owusu, EE Nkrumah, ...
Emerging infectious diseases 19 (3), 456, 2013
5072013
Transmission of MERS-coronavirus in household contacts
C Drosten, B Meyer, MA Müller, VM Corman, M Al-Masri, R Hossain, ...
New England Journal of Medicine 371 (9), 828-835, 2014
4892014
Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections
VM Corman, MA Müller, U Costabel, J Timm, T Binger, B Meyer, P Kreher, ...
Eurosurveillance 17 (49), 20334, 2012
4822012
Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection
VM Corman, AM Albarrak, AS Omrani, MM Albarrak, ME Farah, M Almasri, ...
Clinical Infectious Diseases 62 (4), 477-483, 2016
4782016
Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013
ZA Memish, M Cotten, B Meyer, SJ Watson, AJ Alsahafi, AA Al Rabeeah, ...
Emerging infectious diseases 20 (6), 1012, 2014
4542014
The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies
S Gierer, S Bertram, F Kaup, F Wrensch, A Heurich, A Krämer-Kühl, ...
Journal of virology 87 (10), 5502-5511, 2013
4102013
Temporal and spatial analysis of the 2014–2015 Ebola virus outbreak in West Africa
MW Carroll, DA Matthews, JA Hiscox, MJ Elmore, G Pollakis, A Rambaut, ...
Nature 524 (7563), 97-101, 2015
3812015
MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983–1997
MA Müller, VM Corman, J Jores, B Meyer, M Younan, A Liljander, ...
Emerging infectious diseases 20 (12), 2093, 2014
3802014
Antibodies against MERS coronavirus in dromedary camels, United Arab Emirates, 2003 and 2013
B Meyer, MA Müller, VM Corman, CBEM Reusken, D Ritz, GJ Godeke, ...
Emerging infectious diseases 20 (4), 552, 2014
3722014
SARS-CoV-2 viral load and shedding kinetics
O Puhach, B Meyer, I Eckerle
Nature Reviews Microbiology 21 (3), 147-161, 2023
3512023
Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study
MA Müller, B Meyer, VM Corman, M Al-Masri, A Turkestani, D Ritz, ...
The Lancet Infectious Diseases 15 (5), 559-564, 2015
3312015
Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2
O Puhach, K Adea, N Hulo, P Sattonnet, C Genecand, A Iten, ...
Nature medicine 28 (7), 1491-1500, 2022
3202022
Antibodies against MERS coronavirus in dromedary camels, Kenya, 1992–2013
VM Corman, J Jores, B Meyer, M Younan, A Liljander, MY Said, I Gluecks, ...
Emerging infectious diseases 20 (8), 1319, 2014
2892014
Middle East Respiratory Syndrome coronavirus (MERS-CoV) serology in major livestock species in an affected region in Jordan, June to September 2013
CB Reusken, M Ababneh, VS Raj, B Meyer, A Eljarah, S Abutarbush, ...
Eurosurveillance 18 (50), 2013
2802013
Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland
J Perez-Saez, SA Lauer, L Kaiser, S Regard, E Delaporte, I Guessous, ...
The Lancet Infectious Diseases 21 (4), e69-e70, 2021
2562021
p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro via E3 ubiquitin ligase RCHY1
Y Ma-Lauer, J Carbajo-Lozoya, MY Hein, MA Müller, W Deng, J Lei, ...
Proceedings of the National Academy of Sciences 113 (35), E5192-E5201, 2016
2372016
Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines
MA Müller, VS Raj, D Muth, B Meyer, S Kallies, SL Smits, R Wollny, ...
MBio 3 (6), 10.1128/mbio. 00515-12, 2012
2362012
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20